Proteomic Techniques as Biomarkers for Multiple Sclerosis
Researchers at the Montreal Neurological Institute and other centers in Canada performed proteomics screening of CSF samples collected from 19 children at presentation of acquired inflammatory CNS demyelinating syndromes.
Saved in:
| Main Author: | J Gordon Millichap |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
2012-06-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/542 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Revised Diagnostic Definition of MS
by: J Gordon Millichap, et al.
Published: (2014-07-01) -
Incidence of CNS Demyelinating Syndromes
by: J Gordon Millichap
Published: (2011-11-01) -
Cortical Demyelination in Multiple Sclerosis
by: J Gordon Millichap
Published: (2008-02-01) -
Pediatric Neuroimaging of Multiple Sclerosis and Neuroinflammatory Diseases
by: Chloe Dunseath, et al.
Published: (2024-12-01) -
The fungal gut microbiota in pediatric-onset multiple sclerosis
by: Nelson Mok, et al.
Published: (2024-12-01)